Navigation Links
Climate change poker: The barriers which are preventing a global agreement
Date:8/4/2009

As the world's environment ministers, government officials, diplomats and campaigners prepare to attend the COP15 conference in Copenhagen in December 2009 to unite in the battle against climate change in one of the most complicated political deals the world has ever seen, the increasingly complex territory of climate negotiations is being revealed in an article published today, 5 August, 2009, in IOP Publishing's Environmental Research Letters.

The paper 'Tripping Points: Barriers and Bargaining Chips on the Road to Copenhagen' lays bare the main tripping points political barriers and bargaining chips which need to be overcome for countries to reach a consensus on how to address global climate change.

One of the key issues delegates will face in their attempt to agree on mitigation, is that what some countries see as barriers, others perceive as bargaining chips. While many developed countries, including the UK, favor extending mitigation actions to some developing countries, many developing countries will be using finance and technology transfer as a deal breaker for their consent to the overall deal.

Bargaining is expected to evolve around what is referred to as the 'chicken and egg question', that is whether actions depend on financing, or financing on actions. Researchers predict that similar to a poker game, countries will be delaying decisions until the last hours of the conference when all the bargaining chips will be on the table and parties cannot wait any longer to see who will show their hand first.

Other barriers delegates will face in their bid to reach an agreement on a post-2012 framework are issues evolving around the reduction of emissions from deforestation and forest degradation, and how to implement adaptation to climate change.

Even if some consensus is reached in Copenhagen, there is however no guarantee a deal will be agreed on. Nevertheless, the researchers write "Regardless, howev
'/>"/>

Contact: Lena Weber
lena.weber@iop.org
44-020-747-04896
Institute of Physics
Source:Eurekalert

Page: 1 2

Related biology news :

1. Rodent size linked to human population and climate change
2. Douglas-fir, geoducks make strange bedfellows in studying climate change
3. Warming climate threatens California fruit and nut production
4. Climate change may spell demise of key salt marsh constituent
5. Down Under dinosaur burrow discovery provides climate change clues
6. Seals quickly respond to gain and loss of habitat under climate change
7. Arctic climate under greenhouse conditions in the Late Cretaceous
8. Report shows the power of US cities to mitigate climate change and steps they need to take to adapt
9. New crops needed for new climate
10. New crops needed for new climate
11. New guide to tropical seedlings: Essential to climate change research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2015)... , Feb. 18, 2015  Cepheid (NASDAQ: ... at the following conferences, and invited investors to participate via ... Boston, MA Tuesday, March 3, 2015 at ... Conference, Orlando, FL Wednesday, March 4, ... Webcasts To access the live webcasts for these events, please ...
(Date:2/11/2015)... February 11, 2015 ... "Access Control Market by Product (Cards and Readers, Biometrics, ... Defense, Government, Industrial, Healthcare, Education) and By Geography - Global ... MarketsandMarkets, the Access Control Market is expected ... at a CAGR of 10.6% between 2014 ...
(Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Marken Launches New Patient-Centric Campaign 2
... to many men during their fight against prostate cancer can ... The findings were published online this week in a pair ... of Sciences . The results may help explain a ... common treatment for men with advanced prostate cancer, generally keeps ...
... Additional Funding by Syncom Venture Partners and Participation ... GE Security, Baker Capital and Lehman Brothers., NEW ... airport,security, has secured $44.4 million in venture funding. Led ... second investor Syncom Venture,Partners, and existing investors Lockheed Martin, ...
... the U.S. Environmental Protection Agency (EPA) announced the award of ... to investigate how the sizes and shapes of nanoparticles affect ... largest EPA Science to Achieve Results (STAR) grant ever awarded ... single grant ever awarded by EPA STAR for nanotechnology research. ...
Cached Biology News:Why a common treatment for prostate cancer ultimately fails 2Why a common treatment for prostate cancer ultimately fails 3Why a common treatment for prostate cancer ultimately fails 4Clear(R) Secures $44.4 Million in Venture Funding 2Clear(R) Secures $44.4 Million in Venture Funding 3$2M grant awarded to University of Kentucky for research on nanoparticles and human health 2
(Date:3/2/2015)... , March 2, 2015  Pfenex Inc. (NYSE ... the development of biosimilar therapeutics, today announced that ... Global Healthcare Conference in Miami, FL at the Loews Miami ... executive officer of Pfenex, will provide an overview ... on March 12th at 9:00 am ET. A live audio webcast ...
(Date:3/2/2015)... YORK , March 2, 2015 ... scroll to bottom.   Moments ago, Analysts ... including Sunshine Heart (NASDAQ: SSH ), ... ), Syneron Medical (NASDAQ: ELOS ), Spectranetics (NASDAQ: ... ). Analysts Review provides a single unified platform for investors, ...
(Date:3/2/2015)... , March 2, 2015 VG ... developing therapies for autoimmune and infectious diseases, announced ... has issued an important new composition of matter ... through the targeting of CLIP. ... technology underlying VG Life Sciences, VG1177, a synthetic ...
(Date:3/2/2015)... March 02, 2015 Global ... formed alliance with Shenzhen HANK Bioengineering Co., Ltd. ... The alliance will establish a stem cells training ... China in September 2015. , Shenzhen HANK is ... an award-winning scientist, microbiologist and virologist, to integrate ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3
... BEIJING , June 29 /PRNewswire-Asia-FirstCall/ -- China ... "Company"), a leading organic,compound fertilizer manufacturer and distributor in ... $10 million as a result of the exercise ... IV, L.P. and CAGP IV,Co-Investment, L.P., two affiliates of ...
... June 29 Reportlinker.com announces that a new market ... , , ... Follow-On Biologics: Global Market Outlook 2010-2025 - opportunities and challenges ... , , ...
... "More than meets the eye" may soon become more ... toys. Researchers at Harvard and MIT have reshaped the ... on the ancient art of origami. Called programmable matter ... composed of interconnected triangular sections could transform itself into a ...
Cached Biology Technology:China Agritech, Inc. Receives $10 Million From Warrant Exercise by The Carlyle Group 2China Agritech, Inc. Receives $10 Million From Warrant Exercise by The Carlyle Group 3China Agritech, Inc. Receives $10 Million From Warrant Exercise by The Carlyle Group 4Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 2Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 3Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 4Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 5Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 6Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 7Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 8Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 9Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 10Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 11Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 12Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 13Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 14Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 15Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 16Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 17Reportlinker Adds Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 - Opportunities and Challenges in this Emerging Market With High Potential 18Shape-shifting sheets automatically fold into multiple shapes 2
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... Inhibitor is a potent noncompetitive ... as RNase A. Like other ... Inhibitor is an acidic protein ... kDa. RNaseOUT inhibits RNase A ...
... Inhibitor (Ribonuclease inhibitor) is a ... to inhibit RNase activity. It ... endonuclease activity. , Inhibits ... RNA template , Lacks ...
Canine Aortic Smooth Muscle Cells (CnAOSMC) (>500,000 cells)...
Biology Products: